Video

Renee Amori from Drexel University College of Medicine: Tackling Type 2 Diabetes a Continuing Challenge in Endocrinology

Author(s):

There is no shortage of patients with type 2 diabetes and an equally large number of treatment options available. However, matching the patients to the correct treatment option remains a challenge for endocrinologists and those in the health care community.

%jwplayer%

There is no shortage of patients with type 2 diabetes and an equally large number of treatment options available. However, matching the patients to the correct treatment option remains a challenge for endocrinologists and those in the health care community.

Renee Amori, MD, from the Drexel University College of Medicine discussed how treatment for this condition has progressed and what the future may look like during a recent interview with MD Magazine. In addition to issues with diagnosing the condition Amori said patients also struggle with being able to afford their medications and other treatment forms.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.